The Center’s David Bryden describes a visit to the Bwafwano Community Home Based Care organization in Zambia during a recent Congressional delegate trip to Africa. “Hello, hello! We welcome you to our school!” about 100 clapping children sang as our congressional study tour arrived at the Bwafwano Community Home Based Care organization, run by Executive Director […]
The Center’s Christine Lubinski and Rabita Aziz describe visits to ZAMSTAR’s TB programs in Livingstone and Lusaka, Zambia, during a recent Congressional delegate trip to Africa. Performers dressed in bright green ZAMSTAR uniforms sing louder and clap harder as a large crowd gathers around their truck. Another performer exuberantly walks around in front of the audience […]
Director of The Center for Global Health Policy Christine Lubinski recalls her recent trip to South Africa and Zambia, where she and other Center staff hosted five congressional staff members on tours of U.S. government funded programs to address HIV and TB. Additional resources are essential to scale up prevention and treatment to ultimately reach the tipping point of […]
The Center’s Rabita Aziz describes a visit to Livingstone General Hospital’s antiretroviral therapy (ART) ward in Zambia during a recent Congressional delegate trip to Africa. In a dark room so small and cramped that the door won’t even close, Ndabila Singango, a provincial clinical mentor employed by the Center for Infectious Disease Research of Zambia (CIDRZ), tests […]
While in Lusaka, Zambia with our congressional study tour, I had a chance to speak with some of the leading community activists about issues of concern related to the treatment financing gap, their input into agreements being negotiated between the U.S. and Zambia, and the urgency of Zambia’s pending application to the Global Fund for […]
Male circumcision (MC) was a recurring theme throughout our congressional study tour, since the intervention has been shown to provide up to 60 percent protection for men from HIV infection from a female partner. There is also evidence that it reduces the chance of the female partner contracting some genital infections that could lead to cancer of […]
When Mark Heywood helped found the AIDS Law Project in South Africa in 1993, there were slightly fewer than one million South Africans infected with HIV/AIDS. There was no national antiretroviral treatment (ART) program, and drugs were extremely expensive, making it almost impossible for people living with HIV/AIDS to get treatment. The AIDS Law Project […]
Note: this posting has been revised from the previous version. An analysis developed with the aid of the USAID-funded Deliver Project shows that Zambia is facing a massive gap in the financing required to reach country targets for expanded access to antiretroviral therapy (ART). The gap goes from $8.2 million for 2011 to a whopping […]
HIV
By Murray Penner of Prevention Access Campaign Undetectable = Untransmittable, or U=U, is a clear, effective, simple way to convey the fact that a person living […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]